Results 21 to 30 of about 401,594 (264)

People living in nursing care facilities who are ambulant and fracture their hips: description of usual care and an alternative rehabilitation pathway

BMC Geriatrics, 2020
Background Little is known about treatment provided to people living in nursing care facilities (NCFs) after hospital admission for hip fracture. In addition, there are no clinical guidelines for rehabilitation and recovery following hip fracture for ...
Maggie Killington, Owen Davies, Maria Crotty, Rhiannon Crane, Naomi Pratt, Kylie Mills, Arabella McInnes, Susan Kurrle, Ian D. Cameron   +8 more
doaj   +1 more source

Vitamin B12 and cognitive decline

Annals of Indian Academy of Neurology, 2015
Serdar Tasdemir, Umit Hidir Ulas
doaj   +3 more sources

Increasing the uptake of vitamin D supplement use in Australian residential aged care facilities: results from the vitamin D implementation (ViDAus) study

BMC Geriatrics, 2020
Background Adequate (≥800 IU/day) vitamin D supplement use in Australian residential aged care facilities (RACFs) is variable and non-optimal. The vitamin D implementation (ViDAus) study aimed to employ a range of strategies to support the uptake of this
Pippy Walker, Annette Kifley, Susan Kurrle, Ian D. Cameron   +3 more
doaj   +1 more source

Psychotropic medications in older people in residential care facilities and associations with quality of life: a cross-sectional study

BMC Geriatrics, 2018
Background Psychotropic medications have been associated with many adverse outcomes in older people living in residential care. Home-like models of residential care may be preferable to traditional models of care and we hypothesized that this model may ...
Stephanie L. Harrison, Clare Bradley, Rachel Milte, Enwu Liu, Lisa Kouladjian O’Donnell, Sarah N. Hilmer, Maria Crotty   +6 more
doaj   +1 more source

Subjective Cognitive Decline

Journal of Alzheimer's Disease, 2015
Perceived decline in cognition in the absence of what is commonly termed ‘objective evidence’ is frequently referred to as subjective cognitive decline (SCD). While etiologically heterogeneous and therefore potentially responsive to intervention in some cases, SCD remains primarily associated with an increased risk of developing dementia.
Tales, Andrea, Jessen, Frank, Butler, Christopher, Wilcock, Gordon, Phillips, Judith, Bayer, Tony   +5 more
openaire   +6 more sources

Impacts of baseline biomarkers on cognitive trajectories in subjective cognitive decline: the CoSCo prospective cohort study

Alzheimer’s Research & Therapy, 2023
Background Subjective cognitive decline (SCD) is a risk factor for Alzheimer’s disease (AD); however, the rates of cognitive decline are variable according to underlying pathologies and biomarker status.
Yun Jeong Hong, SeongHee Ho, Jee Hyang Jeong, Kee Hyung Park, SangYun Kim, Min Jeong Wang, Seong Hye Choi, Dong Won Yang, CoSCo study group   +8 more
doaj   +1 more source

Subjective Cognitive Decline and Related Cognitive Deficits

Frontiers in Neurology, 2020
Since late stage dementia, including Alzheimer's disease (AD), cannot be reversed by any available drugs, there is increasing research interest in the preclinical stage of AD, i.e., subjective cognitive decline (SCD).
Tong Si, Guoqiang Xing, Ying Han, Ying Han, Ying Han   +4 more
doaj   +1 more source

Steeper memory decline after COVID-19 lockdown measures

Alzheimer’s Research & Therapy, 2023
Background During COVID-19 lockdown measures, memory clinic patients reported worries for faster cognitive decline, due to loss of structure and feelings of loneliness and depression. We aimed to investigate the impact of the COVID-19 lockdown on rate of
Els D. Bakker, Stéphanie L. van der Pas, Marissa D. Zwan, Freek Gillissen, Femke H. Bouwman, Philip Scheltens, Wiesje M. van der Flier, Ingrid S. van Maurik   +7 more
doaj   +1 more source

Protocol for a non-randomised pilot and feasibility study evaluating a multicomponent intervention to simplify medication regimens for people receiving community-based home care services

BMJ Open, 2019
Introduction Managing medication regimens is one of the most complex and burdensome tasks performed by older people, and can be prone to errors. People living with dementia may require medication administration assistance from formal and informal ...
Sarah N Hilmer, Janet Kathleen Sluggett, Amy Theresa Page, Esa Y H Chen, Jenni Ilomäki, Megan Corlis, Jan Van Emden, Michelle Hogan, Tessa Caporale, Manya Angley, Choon Ean Ooi   +10 more
doaj   +1 more source

Isolated Cognitive Decline in Neurologically Stable Patients with Multiple Sclerosis

Diagnostics, 2021
(1) Background: Cognitive deterioration is an important marker of disease activity in multiple sclerosis (MS). It is vital to detect cognitive decline as soon as possible. Cognitive deterioration can take the form of isolated cognitive decline (ICD) with
Jiri Motyl, Lucie Friedova, Manuela Vaneckova, Jan Krasensky, Balazs Lorincz, Jana Blahova Dusankova, Michaela Andelova, Tom A. Fuchs, Eva Kubala Havrdova, Ralph H. B. Benedict, Dana Horakova, Tomas Uher   +11 more
doaj   +1 more source